PlusVitech secures three million euros in public–private funding for its advanced lung cancer drug
The Seville-based biotech closes a private investment round of 500,000 euros and receives 2.5 million euros in non-repayable funding from CDTI thanks to the European Seal of Excellence. The round, ratified on December 17, brings in Dr. Leni Ramos (San Francisco) as an investor and new Chief Medical Officer (CMO) and co-CEO of the company.…